Please assess the completion status of the following clinical trial:

Trial Title: Treatment Of Alcohol Withdrawal Syndrome: Dexmedetomidine Vs Diazepam In A Hospital O'horán

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients who received dexmedetomidine during their Emergency stay~* Patients who received diazepam during their Emergency stay~* CIE-10 codes consistent with alcohol withdrawal during hospitalization~* CIWA-A score \>10 points~Exclusion Criteria:~* comorbid disease, including several with CNS trauma or cerebrovascular accidents, one with end-stage metastatic carcinoma, and one patient with severe sepsis.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Dexmedetomidine (Type: SHAM_COMPARATOR): Dexmedetomidine. Dexmedetomidine use 400 mcg in 100 cc 0.9% physiological solution in continuous infusion starting at a dose of 0.2 mcg / kg / hr titrating until reaching a decrease in the adrenergic response, with a maximum dose of 0.7 mcg / kg / hr7.~Dosage form: DEX 0.2-0.7 mcg/Kg/min.
- Diazepam (Type: ACTIVE_COMPARATOR): Dosage form: Diazepam 5-10 mg IV, steps until a maximum dose of 120 mg diazepam

Based on this trial design, predict the completion outcome and termination type (if applicable).